As reports show, with the expiry of Novo Nordisks semaglutide exclusivity on January 4, 2026, Canada has emerged as the first major Western market where generic semaglutide can be legally produced and sold, subject to Health Canada approval
About The Authors: Brandon Miller is a data-driven, people-focused health equity strategist and organizational transformation leader at Clarkston Consulting
The situation becomes more concerning for diabetic patients using these medications, as their risk of intestinal obstruction jumps 4.5 times higher compared to those using other glucose control options
Seek medical advice if you experience: New or worsening vision problems Severe or progressive weakness Loss of coordination or balance Confusion or cognitive changes Seizures These symptoms could indicate underlying conditions requiring investigation
Individuals with a BMI over 25 and metabolic symptoms, or a BMI over 30, may be considered following a medical evaluation